Méthodologie de l'évaluation des médicaments chez la femme enceinte
作者： Marina Chauvenet , Alain Rimailho , Nathalie Hoog-Labouret , F. Audibert , F. Bavoux
关键词:
摘要: Objet de reticences diverses, la prescription medicamenteuse chez femme enceinte repond pourtant a une absolue necessite dans un certain nombre cas. Une evaluation correcte du medicament s'impose donc, axee sur l'efficacite et securite ou essentiellement securite, selon l'experience disponible en dehors grossesse. La methodologie d'evaluation ne pas necessairement des caracteristiques particulieres. Des recommandations developpement sont formulees suivant les situations plus frequentes ainsi que propositions concretes, pour permettre meilleure sensibilisation differents partenaires sante impliques (institutions, industriels prescripteurs). En particulier, incitations d'ordre reglementaire economique, superposables celles adoptees Europe aux Etats-Unis maladies orphelines, devraient etre mises place favoriser l'evaluation obstetricale medicament.
paperity.org参考文章(15)
E Papiernik, P Senanedj, B Topuz, J Zeitlin, M Bucourt, Évolution de la régionalisation des soins périnatals dans le département de la Seine-Saint-Denis de 1989 à 1999 Journal De Gynecologie Obstetrique Et Biologie De La Reproduction. ,vol. 30, pp. 338- 343 ,(2001)
Roulot C, Bourget P, Fernandez H, [Transplacental transport and feto-placental metabolism of drugs: study methods, therapeutic contributions and implications]. Therapie. ,vol. 49, pp. 481- 497 ,(1994)
I Lacroix, C Damase-Michel, M Lapeyre-Mestre, JL Montastruc, Prescription of drugs during pregnancy in France. The Lancet. ,vol. 356, pp. 1735- 1736 ,(2000) , 10.1016/S0140-6736(00)03209-8
Brian M. Casey, Roger E. Bawdon, Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model American Journal of Obstetrics and Gynecology. ,vol. 179, pp. 758- 761 ,(1998) , 10.1016/S0002-9378(98)70078-X
MARK MIROCHNICK, ALEX DORENBAUM, DIANE HOLLAND, BETHANN CUNNINGHAM-SCHRADER, COLLEEN CUNNINGHAM, RICHARD GELBER, LYNNE MOFENSON, MARY CULNANE, JAMES CONNOR, JOHN L. SULLIVAN, Concentrations of protease inhibitors in cord blood after in utero exposure. Pediatric Infectious Disease Journal. ,vol. 21, pp. 835- 838 ,(2002) , 10.1097/00006454-200209000-00010
V TSATSARIS, Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis1 Obstetrics & Gynecology. ,vol. 97, pp. 840- 847 ,(2001) , 10.1016/S0029-7844(00)01212-6
Ronen Loebstein, Arieh Lalkin, Gideon Koren, Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance Clinical Pharmacokinectics. ,vol. 33, pp. 328- 343 ,(1997) , 10.2165/00003088-199733050-00002
Paolo Mazzotta, Laura A. Magee, A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs. ,vol. 59, pp. 781- 800 ,(2000) , 10.2165/00003495-200059040-00005
Tove Tuntland, Aleksandrs Odinecs, Conrad M. Pereira, Connie Nosbisch, Jashvant D. Unadkat, In vitro models to predict the in vivo mechanism, rate and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus American Journal of Obstetrics and Gynecology. ,vol. 180, pp. 198- 206 ,(1999) , 10.1016/S0002-9378(99)70175-4
Laura J. Rosen, David Zucker, Vered Oppenheimer-Gazit, Simcha Yagel, The great tocolytic debate: some pitfalls in the study of safety. American Journal of Obstetrics and Gynecology. ,vol. 184, pp. 1- 7 ,(2001) , 10.1067/MOB.2001.109595